Literature DB >> 26392978

A nested case-control study on relapse predictors among tuberculosis patients treated in Yemen's NTCP.

M S Anaam1, M I M Ibrahim2, A W Al Serouri3, A Bassili4, A Aldobhani1.   

Abstract

SETTING: The National Tuberculosis (TB) Control Programme in Yemen.
OBJECTIVE: To identify risk factors associated with TB relapse.
METHODS: In a prospective nested case-control study, relapse cases were recruited from a cohort of pulmonary TB patients registered between July 2007 and June 2008. Four controls per case were randomly selected from the list of non-relapse patients. Three forms were used for data collection, which included interviews with the participants and review of their medical cards and TB registers. Multivariate logistic regression analysis was performed to identify independent risk factors for relapse.
RESULTS: A relapse rate of 5.7% was found. Multivariate logistic regression analysis showed that unemployment, smoking, presence of cavitations, weight gain, weight loss, non-adherence during the continuation phase and diabetes were significantly associated with relapse (P < 0.05).
CONCLUSION: Relapse rates can be reduced by ensuring that patients take their treatment regularly and are counselled effectively to stop smoking. Reinforcing the implementation of the DOTS strategy and strengthening the anti-smoking campaigns are important actions. Action to help unemployed patients, including free services and the creation of new job opportunities, should be adopted. Using rifampicin-based regimens in the treatment of cavitary TB and bi-directional screening in TB and diabetes patients are recommended.

Entities:  

Keywords:  Yemen; nested case-control study; relapse; tuberculosis

Year:  2012        PMID: 26392978      PMCID: PMC4463052          DOI: 10.5588/pha.12.0044

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  30 in total

1.  Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

Authors:  A van Rie; R Warren; M Richardson; T C Victor; R P Gie; D A Enarson; N Beyers; P D van Helden
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  Smoking, iron, and tuberculosis.

Authors:  Johan R Boelaert; Maria Salomé Gomes; Victor R Gordeuk
Journal:  Lancet       Date:  2003-10-11       Impact factor: 79.321

3.  A simple method of sample size calculation for linear and logistic regression.

Authors:  F Y Hsieh; D A Bloch; M D Larsen
Journal:  Stat Med       Date:  1998-07-30       Impact factor: 2.373

4.  HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers.

Authors:  P Sonnenberg; J Murray; J R Glynn; S Shearer; B Kambashi; P Godfrey-Faussett
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

5.  Lack of weight gain and relapse risk in a large tuberculosis treatment trial.

Authors:  Awal Khan; Timothy R Sterling; Randall Reves; Andrew Vernon; C Robert Horsburgh
Journal:  Am J Respir Crit Care Med       Date:  2006-05-18       Impact factor: 21.405

6.  Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India.

Authors:  A Thomas; P G Gopi; T Santha; V Chandrasekaran; R Subramani; N Selvakumar; S I Eusuff; K Sadacharam; P R Narayanan
Journal:  Int J Tuberc Lung Dis       Date:  2005-05       Impact factor: 2.373

7.  Radiological manifestations of pulmonary tuberculosis.

Authors:  J Andreu; J Cáceres; E Pallisa; M Martinez-Rodriguez
Journal:  Eur J Radiol       Date:  2004-08       Impact factor: 3.528

8.  Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar.

Authors:  T M Comolet; R Rakotomalala; H Rajaonarioa
Journal:  Int J Tuberc Lung Dis       Date:  1998-11       Impact factor: 2.373

9.  Recurrent tuberculosis in the United States and Canada: relapse or reinfection?

Authors:  Robert M Jasmer; Lorna Bozeman; Kevin Schwartzman; M Donald Cave; Jussi J Saukkonen; Beverly Metchock; Awal Khan; William J Burman
Journal:  Am J Respir Crit Care Med       Date:  2004-10-11       Impact factor: 21.405

10.  Evaluation of new anti-infective drugs for the treatment and prevention of tuberculosis. Infectious Diseases Society of America and the Food and Drug Administration.

Authors:  P Hopewell; M Cynamon; J Starke; M Iseman; R O'Brien
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

View more
  5 in total

Review 1.  Diabetes-related tuberculosis in the Middle East: an urgent need for regional research.

Authors:  Yosra M Alkabab; Hail M Al-Abdely; Scott K Heysell
Journal:  Int J Infect Dis       Date:  2015-09-25       Impact factor: 3.623

Review 2.  Undernutrition is feeding the tuberculosis pandemic: A perspective.

Authors:  Madeline E Carwile; Natasha S Hochberg; Pranay Sinha
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2022-03-17

3.  Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study.

Authors:  Hin Moi Youn; Moon-Kyung Shin; Dawoon Jeong; Hee-Jin Kim; Hongjo Choi; Young Ae Kang
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

4.  The incidence of recurrence of tuberculosis and its related factors in smear-positive pulmonary tuberculosis patients in Iran: A retrospective cohort study.

Authors:  Mahmood Moosazadeh; Abbas Bahrampour; Mahshid Nasehi; Narges Khanjani
Journal:  Lung India       Date:  2015 Nov-Dec

5.  Tuberculosis recurrences and predictive factors in a vulnerable population in Catalonia.

Authors:  Sílvia Brugueras; Vinicio-Israel Molina; Xavier Casas; Yoel-Domingo González; Nuria Forcada; Dora Romero; Anna Rodés; Maria-Neus Altet; José Maldonado; Mario Martin-Sánchez; Joan A Caylà; Àngels Orcau; Cristina Rius; Joan-Pau Millet
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.